30 results match your criteria: "Henry Ford Health Science Center[Affiliation]"
Clin Breast Cancer
June 2015
Department of Radiation Oncology, Cross Cancer Institute, Edmonton, AB, Canada. Electronic address:
Background: The efficacy of aloe extract in reducing radiation-induced skin injury is controversial. The purpose of the present 3-arm randomized trial was to test the efficacy of quality-tested aloe extract in reducing the severity of radiation-induced skin injury and, secondarily, to examine the effect of a moist cream versus a dry powder skin care regimen.
Materials And Methods: A total of 248 patients with breast cancer were randomized to powder, aloe cream, or placebo cream.
J Exp Clin Cancer Res
July 2008
Department of Neurology, Henry Ford Health Science Center, Detroit, MI, USA.
Heparanase is an endoglycosidase that degrades heparan sulfate, the main polysaccharide constituent of the extracellular matrix (ECM) and basement membrane. Expression of the heparanase gene is associated with the invasion and metastatic potential of a variety of tumor-derived cell types. However, the roles of heparanase in the regulation of gene expression and the subsequent cell function changes other than invasion are not clear.
View Article and Find Full Text PDFBr J Pharmacol
August 2007
Department of Neurology, Henry Ford Health Science Center, 2799 West Grand Boulevard, Detroit, MI 48202, USA.
Background And Purpose: Recombinant human erythropoietin (rhEPO; Epoetin-alpha; PROCRITtrade mark) has been shown to exert neuroprotective and restorative effects in a variety of CNS injury models. However, limited information is available regarding the dose levels required for these beneficial effects or the neuronal responses that may underlie them. Here we have investigated the dose-response to rhEPO and compared the effects of rhEPO with those of carbamylated rhEPO (CEPO) in a model of cerebral stroke in rats.
View Article and Find Full Text PDFJ Exp Ther Oncol
July 2007
Department of Neurosurgery, Henry Ford Health Science Center, Detroit, MI 48202, USA.
Vascular endothelial growth factor (VEGF) is abundantly produced by glioma cells especially glioblastoma, the most malignant form of astrocytoma. VEGF, a well known angiogenic factor, acts in a paracrine fashion on endothelial cells to develop tumor vasculature. However, recent studies have found that several tumor cells express VEGF receptors, and an autocrine action of VEGF on tumor cells has been suggested.
View Article and Find Full Text PDFExp Eye Res
December 2001
Eye Care Services, Henry Ford Health Science Center, One Ford Place, Detroit, MI 48202, USA.
This study was undertaken to determine whether experimental retinal detachment produces changes in retinal localization of three isoforms of transforming growth factor beta (TGF-beta) and the type II receptor for this protein. Neural retinas of young adult cats were detached from the pigment epithelium. Survival times varied from 3 to 28 days to study the temporal course of TGF-beta localization during retinal degeneration.
View Article and Find Full Text PDFJ Invest Dermatol
August 2000
Department of Dermatology, Henry Ford Health Science Center, Detroit, MI and Department of Biochemistry and HHMI, NYU Medical Center, New York, NY.
Clin Cancer Res
April 2000
Department of Neurosurgery, Henry Ford Health Science Center, Detroit, Michigan 48202, USA.
Carboxyamido-triazole (CAI), an inhibitor of non-voltage-gated calcium channels, has been studied in Phase I/II clinical trials following the identification of its inhibitory effects on tumor cell invasion and motility. It has also been reported to inhibit human endothelial cell proliferation, migration, and adhesion to the basement membrane. In glioma, biological assays have shown CAI to be active in inhibiting the phenotypes of invasion and angiogenesis.
View Article and Find Full Text PDFStroke
February 2000
Departments of Neurology, Henry Ford Health Science Center, Detroit, MI, USA.
Background And Purpose: Intravenous tissue plasminogen activator (tPA) administered within 3 hours of symptom onset is the first available effective therapy for acute ischemic stroke (AIS). Few data exist, however, on its use in very elderly patients. We examined the characteristics, complications, and short-term outcome of AIS patients aged >/=80 years treated with tPA.
View Article and Find Full Text PDFBrain Res
November 1999
Department of Neurology, Henry Ford Health Science Center, Detroit, MI 48202, USA.
Tie 1 is an endothelial specific transmembrane receptor tyrosine kinase and may be required during angiogenesis. Using in situ hybridization, we measured tie 1 mRNA in ischemic brain (n=15). Rats were subjected to middle cerebral artery (MCA) occlusion by a single fibrin rich clot.
View Article and Find Full Text PDFStroke
November 1998
Center for Stroke Research, Department of Neurology, Henry Ford Health Science Center (Detroit Campus of Case Western University), Detroit, Mich., USA.
Background And Purpose: The aim of our study was to characterize the patient profile and prognostic value associated with high positive IgG (>100 GPL) anticardiolipin antibodies (aCL).
Methods: We studied the clinical, laboratory, radiological, and prospective historical features of ischemic cerebrovascular disease in patients with >100 GPL titers. From our neurology department, 27 consecutive patients were prospectively identified and followed up (mean follow-up time, 34 months).
J Neurol Sci
April 1998
Department of Neurology, Henry Ford Health Science Center, Detroit, MI 48202, USA.
Middle cerebral artery occlusion (MCAo) leads to brain cell death. However, quantitation of injured brain cells and inflammatory cells after MCAo has not been determined in the rat. Transient (2 h) MCAo was therefore induced in male Wistar rats by means of an intraluminal monofilament.
View Article and Find Full Text PDFJ Cereb Blood Flow Metab
October 1997
Department of Neurology, Henry Ford Health Science Center, Detroit, Michigan 48202, U.S.A.
We developed a mouse model of embolic focal cerebral ischemia, in which a fibrin-rich clot was placed at the origin of the middle cerebral artery (MCA) in C57BL/6J mice (n = 31) and B6C3 mice (n = 10). An additional three non-embolized C57BL/6J mice were used as a control. Embolus induction, cerebral vascular perfusion deficit, and consequent ischemic cell damage were confirmed by histopathology, immunohistochemistry, laser confocal microscopy, and regional cerebral blood flow (rCBF) measurements.
View Article and Find Full Text PDFJ Neurol Sci
September 1997
Department of Neurology, Henry Ford Health Science Center, Detroit, MI 48202, USA.
We investigated the relationship between apoptosis and selective protein expression in brain from rats subjected to 8 (n=10) or 12 min (n=10) of forebrain ischemia and 48 h of reperfusion, and control sham operated (n=2) and normal (n=2). Coronal sections were processed for double staining with DNA fragmentation detection and immunohistochemical staining. In five of ten 8-min ischemic and three of ten 12-min ischemic animals, nearly all dead granule cells within the dentate gyrus exhibited apoptotic morphology.
View Article and Find Full Text PDFJ Cereb Blood Flow Metab
August 1997
Department of Neurology, Henry Ford Health Science Center, Detroit, Michigan, USA.
We investigated the expression of cyclin D1 and its kinase, cdk4, after induction of focal cerebral ischemia in the rat. Brain from rats (n = 6) subjected to 2 hours of transient middle cerebral artery occlusion and 46 hours of reperfusion, and control sham-operated (n = 3) and normal (n = 2) rats were processed for dual label immunohistochemical study for cellular identification of the expression of these cell cycle proteins. Antibodies raised against microtubule-associated protein 2 and neuronal specific enolase for neurons, glial fibrillary acidic protein for astrocytes, myelin basic protein for oligodendrocytes and lectin histochemical study with the B4-isolectin for microglia were used for cell type identification.
View Article and Find Full Text PDFEur J Pharmacol
February 1997
Henry Ford Health Science Center, Department of Neurology, Detroit, MI 48202, USA.
Endogenous adenosine released locally during cerebral ischemia is neuroprotective, and agents which decrease adenosine inactivation may potentiate its protective effects. The effects of 5'-deoxy-5-iodotubercidin (5'd-5IT), an inhibitor of the adenosine-catabolizing enzyme, adenosine kinase, were studied in male Wistar rats subjected to 2 h of transient middle cerebral artery occlusion. 5'd-5IT or the vehicle (10% DMSO in saline) was administered i.
View Article and Find Full Text PDFJ Cereb Blood Flow Metab
February 1997
Department of Neurology, Henry Ford Health Science Center, Detroit, Michigan, USA.
We developed a fibrin-rich thrombotic focal cerebral ischemic model with reproducible and predictable infarct volume in rats. In male Wistar rats (n = 77), a thrombus was induced at the origin of the middle cerebral artery (MCA) by injection of thrombin via an intraluminal catheter placed in the intracranial segment of the internal carotid artery (ICA). Thrombus induction and consequent ischemic cell damage were examined by histopathological analysis and neurological deficit scoring, and by measuring changes in cerebral blood flow (CBF) using laser-Doppler flowmetery (LDF), perfusion-weighted imaging (PWI), and by diffusion weighted imaging (DWI).
View Article and Find Full Text PDFBrain Res
January 1997
Department of Neurology, Henry Ford Health Science Center, Detroit, MI 48202, USA.
We measured the time-dependent morphological changes of microglial cells reacting to ischemic cell damage after transient (2 h) middle cerebral artery occlusion in the rat by means of lectin histochemistry with the B4-isolectin from Griffonia simplicifolia as well as immunohistochemistry with monoclonal antibodies directed against monocyte/microphage (ED1) and major histocompatibility complex (MHC) class II (OX-6) antigens. As early as 1 h after onset of reperfusion, microglia were absent in the severely neuronal damaged preoptic area. However, ameboid-like microglia were evident in an adjacent area containing scattered shrunken neurons.
View Article and Find Full Text PDFJ Neurol Sci
January 1997
Department of Neurology, Henry Ford Health Science Center, Detroit, MI 48201, USA.
We have developed a multiparameter magnetic resonance imaging (MRI) cluster analysis model of acute ischemic stroke using T2 relaxation times and the diffusion coefficient of water (ADCw). To test the ability of this model to predict cerebral infarction, male Wistar rats (n = 7) were subjected to 2 h of transient middle cerebral artery (MCA) occlusion, and diffusion and T2 weighted MRI were performed on these rats before, during and up to 7 days after MCA occlusion. MRI tissue signatures, specified by values of ADCw and T2 were assigned to tissue histopathology.
View Article and Find Full Text PDFPhotochem Photobiol
October 1996
Henry Ford Health Science Center, Neurology Department, Detroit, MI, USA.
We measured the response of normal brain and the human U87 glioma implanted in the brain of rats (n = 65) to photodynamic therapy (PDT) using Photofrin as the sensitizer. Normal brain and U87 tumor implanted within brain of athymic (nude) rats were subjected to PDT (12.5 mg/kg of Photofrin) at increasing optical energy doses (35 J/cm2, 140 J/cm2, 280 J/cm2) of 632 nm light.
View Article and Find Full Text PDFBrain Res
September 1996
Henry Ford Health Science Center, Neurology Department, Detroit, MI 48202, USA.
Progesterone (PROG) is a neurosteroid, possessing a variety of functions in the central nervous system. Exogenous PROG has been shown to reduce secondary neuronal loss in conjunction with attenuated brain edema after cerebral contusion and to reduce brain edema after focal cerebral ischemia. In the present study, we assessed the neuroprotective potential of PROG in a model of focal cerebral ischemia in the rat.
View Article and Find Full Text PDFOphthalmology
September 1996
Department of Ophthalmology, Henry Ford Health Science Center, Detroit, MI, USA.
Purpose: The authors examined the influences of diabetes on the results of visual function testing in patients with ocular hypertension (OHT).
Methods: Color vision (desaturated D-15), contrast sensitivity together with both transient and steady-state pattern electroretinogram (PERG) findings from patients with documented OHT were examined in a historic cohort study. All patients were examined at least four times (mean, 7.
J Neurol Sci
June 1996
Department of Neurology, Henry Ford Health Science Center, Detroit, MI 482202, USA.
The competitive N-methyl-D-aspartate antagonist MDL-100,453 has been shown to attenuate ischemic cell damage when administered after permanent focal cerebral ischemia. The aim of the present study was to measure the dose-response of cerebral infarcted volume to the agent administered 30 min after permanent middle cerebral artery occlusion and to test whether short-term infusion of this drug reduces ischemic cell damage. Thirty-five Sprague-Dawley rats were randomly assigned to 4 groups: low dose group, a bolus of 12.
View Article and Find Full Text PDFCurr Opin Neurol
February 1996
Neurology Department, Henry Ford Health Science Center, Detroit, MI 48202, USA.
In this review we focus on recent efforts designed to elucidate the role of inflammatory cells and nitric oxide in promoting cerebral ischemic cell damage, the mechanisms by which these events exacerbate ischemic cell damage, and the associated therapeutic interventions to protect tissue from ischemic injury.
View Article and Find Full Text PDFActa Neurochir Suppl
November 1996
Department of Neurology, Henry Ford Health Science Center, Detroit, MI, USA.
An ischemic insult to the brain evokes cell damage which may progress to cell death. We invariably associated cell death with necrosis. Necrosis exhibits well defined morphological characteristics, and the biochemical and biophysical processes associated with necrosis have been identified.
View Article and Find Full Text PDFAnn Neurol
December 1995
Department of Neurology, Henry Ford Health Science Center, Detroit, MI, USA.
We tested the neuroprotective potential of neutrophil inhibitory factor (rNIF), a novel 41-kd recombinant glycoprotein derived from a hookworm, in a model of focal cerebral ischemia in the rat. Male Wistar rats were assigned to treatment with rNIF and vehicle. Middle cerebral artery occlusion (MCAO) for 2 hours was induced by insertion of an intraluminal suture.
View Article and Find Full Text PDF